In­cyte turns to Penn for a col­lab­o­ra­tion on next-gen can­cer com­bos

In­cyte has signed off on a mul­ti-year deal to col­lab­o­rate with sci­en­tists at the Uni­ver­si­ty of Penn­syl­va­nia on its next-gen com­bos and can­cer ther­a­pies. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER